
Profitability, historical returns, and peer comparisons.
According to SpyGlass Pharma, Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -75.64%. This represents a change of -3161.48% compared to the average of 2.47% of the last 4 quarters.
The mean historical ROE of SpyGlass Pharma, Inc. Common Stock over the last ten years is 40.34%. The current -75.64% ROE has changed -287.52% with respect to the historical average. Over the past ten years (40 quarters), SGP's ROE was at its highest in in the December 2025 quarter at 12.70%. The ROE was at its lowest in in the June 2026 quarter at -8.55%.
Average
40.34%
Median
40.34%
Minimum
40.34%
Maximum
40.34%
Discovering the peaks and valleys of SpyGlass Pharma, Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 40.34%
Minimum Annual Increase = 0%
Minimum Annual ROE = 40.34%
| Year | ROE | Change |
|---|
The current ROE of SpyGlass Pharma, Inc. Common Stock (SGP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
40.34%
5-year avg
40.34%
10-year avg
40.34%
SpyGlass Pharma, Inc. Common Stock’s ROE is greater than Glaukos Corporation (-24.91%), greater than Ocular Therapeutix, Inc. (-59.87%), greater than RxSight, Inc. (-17.35%), less than STAAR Surgical Company (1.08%), greater than Bausch + Lomb Corporation (-1.73%), less than Alcon Inc. (2.91%), greater than Sight Sciences, Inc. (-50.64%), greater than Oculis Holding AG (-42.92%), greater than EyePoint Pharmaceuticals, Inc. (-135.81%),
| Company | ROE | Market cap |
|---|---|---|
| -24.91% | $14.37B | |
| -59.87% | $1.49B | |
| -17.35% | $202.77M | |
| 1.08% | $1.28B | |
| -1.73% | $7.18B | |
| 2.91% | $35.76B | |
| -50.64% | $521.56M | |
| -42.92% | $485.62M | |
| -135.81% | $31.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SpyGlass Pharma, Inc. Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SpyGlass Pharma, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is SpyGlass Pharma, Inc. Common Stock's ROE?
How is the ROE calculated for SpyGlass Pharma, Inc. Common Stock (SGP)?
What is the highest ROE for SpyGlass Pharma, Inc. Common Stock (SGP)?
What is the 3-year average ROE for SpyGlass Pharma, Inc. Common Stock (SGP)?
What is the 5-year average ROE for SpyGlass Pharma, Inc. Common Stock (SGP)?
How does the current ROE for SpyGlass Pharma, Inc. Common Stock (SGP) compare to its historical average?